Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,37%
1.076,55
-14,96
-1,37%
—1.091,511.090,401.090,401.077,53——
SIXC
Communications
SIXC
Communications
SIXC
-0,50%
607,03
-3,08
-0,50%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,87%
1.248,72
+10,74
+0,87%
—1.237,981.237,831.252,411.225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,23%
1.723,30
-21,41
-1,23%
—1.744,711.740,951.747,291.727,04——
SIXM
Financials
SIXM
Financials
SIXM
-0,49%
637,06
-3,12
-0,49%
—640,18639,92643,19636,70——
SIXR
Staples
SIXR
Staples
SIXR
-0,48%
845,46
-4,12
-0,48%
—849,58845,27851,68841,28——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,43%
216,54
-0,94
-0,43%
—217,48217,48218,16216,39——
SIXT
Technology
SIXT
Technology
SIXT
-0,52%
3.243,63
-17,06
-0,52%
—3.260,693.273,363.287,813.249,74——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,32%
939,48
-2,97
-0,32%
—942,45939,39948,80934,04——
SIXV
Health care
SIXV
Health care
SIXV
-0,33%
1.461,94
-4,86
-0,33%
—1.466,801.464,701.467,191.458,68——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1,02%
2.373,34
-24,16
-1,02%
—2.397,502.395,032.412,012.376,08——
BAYN:ETR
Bayer AG
37,40 €
-1,71%
(-0,65) 1D
4 may, 17:35:27 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BAYN...
Açın
38,11 €
High
38,73 €
Low
37,24 €
Mkt. cap
37,00 mlrd
Avg. vol.
2,80 mln
Volume
1,94 mln
Dividend
0,29%
Quarterly dividend
0,03 €
Ex dividend date
27 apr 2026
52-wk high
49,78 €
52-wk low
22,02 €
EPS
-3,68 €
Shares outstanding
982,42 mln
No. of employees
87K
News stories
From sources across the web
Profile
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index. Bayer was founded in 1863 in Barmen as a partnership between dye salesman Friedrich Bayer and dyer Johann Friedrich Weskott. The company was established as a dyestuffs producer, but the versatility of aniline chemistry led Bayer to expand its business into other areas. In 1899, Bayer launched the compound acetylsalicylic acid under the trademarked name Aspirin. Aspirin is on the World Health Organization's List of Essential Medicines. In 2021, it was the 34th most commonly prescribed medication in the United States, with more than 17 million prescriptions. In 1904, Bayer received a trademark for the "Bayer Cross" logo, which was, from 1910, subsequently stamped onto each aspirin tablet, creating an enduring brand image. Wikipedia
About Bayer AG
CEOBill Anderson
Employees87,3K
Founded1 avq 1863
Headquarters-
SectorPharmaceutical industry
Websitebayer.com
Next call 8 gün ərzində
12 may, Ç.a., 03:00
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (2,25 est.)EUR
Revenue / Estimate
-/ (13,49 mlrd est.)EUR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
13,74 mlrd
10,74 mlrd
9,66 mlrd
11,44 mlrd
Cost of goods sold
5,62 mlrd
4,73 mlrd
4,31 mlrd
4,23 mlrd
Cost of revenue
5,62 mlrd
4,73 mlrd
4,31 mlrd
4,23 mlrd
Research and development expenses
1,46 mlrd
1,50 mlrd
1,50 mlrd
1,29 mlrd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,71 mlrd
3,77 mlrd
3,40 mlrd
5,37 mlrd
Operating expense
5,79 mlrd
5,02 mlrd
5,90 mlrd
3,89 mlrd
Total operating expenses
11,41 mlrd
9,74 mlrd
10,20 mlrd
8,12 mlrd
Operating income
2,32 mlrd
994,00 mln
-543,00 mln
3,32 mlrd
Other non operating income
-264,00 mln
-333,00 mln
-7,00 mln
1,51 mlrd
EBT including unusual items
1,83 mlrd
-426,00 mln
-1,16 mlrd
-3,37 mlrd
EBT excluding unusual items
1,83 mlrd
574,00 mln
-1,16 mlrd
4,63 mlrd
Income tax expense
526,00 mln
-236,00 mln
-202,00 mln
378,00 mln
Effective tax rate
28,74%
55,40%
17,40%
-11,21%
Other operating expenses
624,00 mln
-249,00 mln
993,00 mln
-2,76 mlrd
Net income
1,30 mlrd
-199,00 mln
-963,00 mln
-3,76 mlrd
Net profit margin
9,46%
-1,85%
-9,97%
-32,85%
Earnings per share
-
1,23
0,57
-
Interest and investment income
-
-
-
471,00 mln
Interest expense
-244,00 mln
-62,00 mln
-539,00 mln
-527,00 mln
Net interest expenses
-244,00 mln
-62,00 mln
-539,00 mln
-56,00 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
3,47 mlrd
1,35 mlrd
412,00 mln
4,72 mlrd
Gain or loss from assets sale
-15,00 mln
-230,00 mln
-33,00 mln
-191,00 mln
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer